|
|
|
| XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in epithelial ovarian carcinoma |
| WANG Lianyun,LV Jieqiang,ZHU Xueqiong,HUANG Qiusui,CHEN Xiaoming,XIA Lu,CHEN Wenbing |
|
| Cite this article: |
|
WANG Lianyun,LV Jieqiang,ZHU Xueqiong, et al. XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in epithelial ovarian carcinoma[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2013, 43(4): 223-227.
|
| [1] |
. [J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2022, 52(9): 0-. |
|
|
|
|
